EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder

Laura Vilar-Ribó iD, Cristina Sánchez-Mora iD, Paula Rovira, Vanesa Richarte, Montserrat Corrales, Christian Fadeuilhe, Lorena Arribas, Miquel Casas, Josep Antoni Ramos-Quiroga, Marta Ribasés iD, María Soler Artigas iD

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2021-04 · 186 (3) · 140-150

DOI: 10.1002/ajmg.b.32827 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, online erschienen am 27.11.2020. Verfasst von Laura Vilar-Ribó und 10 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelo…. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundació la Marató de TV3, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Substance use disorder (SUD) often co‐occur at high prevalence with other psychiatric conditions. Among them, attention‐deficit and hyperactivity disorder (ADHD) is present in almost one out of every four subjects with SUD and is associated with higher severity, more frequent polysubstance dependence and increased risk for other mental health problems in SUD patients. Despite studies suggesting a genetic basis in the co‐occurrence of these two conditions, the genetic factors involved in the joint development of both disorders and the mechanisms mediating these causal relationships are still unknown. In this study, we tested whether the genetic liability to five SUD‐related phenotypes share a common background in the general population and clinically diagnosed ADHD individuals from an in‐house sample of 989 subjects and further explored the genetic overlap and the causal relationship between ADHD and SUD using pre‐existing GWAS datasets. Our results confirm a common genetic background between ADHD and SUD and support the current literature on the causal effect of the liability to ADHD on the risk for SUD. We added novel findings on the effect of the liability of lifetime cannabis use on ADHD and found evidence of shared genetic background underlying SUD in general population and in ADHD, at least for lifetime cannabis use, alcohol dependence and smoking initiation. These findings are in agreement with the high comorbidity observed between ADHD and SUD and highlight the need to control for substance use in ADHD and to screen for ADHD comorbidity in all SUD patients to provide optimal clinical interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Predisposition to DiseaseAdolescentAdultAttention Deficit Disorder with HyperactivityCase-Control StudiesComorbidityHumansMalePrevalencePsychiatric Status Rating ScalesRisk FactorsSpainSubstance-Related Disorders

Stichwörter der Autor:innen

Mendelian randomizationattention-deficit and hyperactivity disordergenetic correlationpolygenic risk scoresubstance use disorder

Autor:innen und Institutionen

  • Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Biomedical Network Research Centre on Mental Health (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Genetics, Microbiology, and Statistics, Faculty of Biology, Universitat de Barcelona, Barcelona, Spain.
  • Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

ORCID-Profile: Laura Vilar-Ribó, Cristina Sánchez-Mora, Marta Ribasés, María Soler Artigas

Förderung

  • Fundació la Marató de TV3
  • Instituto de Salud Carlos III

Zitieren

APA

Vilar-Ribó, L., Sánchez-Mora, C., Rovira, P., Richarte, V., Corrales, M., Fadeuilhe, C., Arribas, L., Casas, M., Ramos-Quiroga, J. A., Ribasés, M., & Soler Artigas, M. (2021). Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 186(3), 140-150. https://doi.org/10.1002/ajmg.b.32827

Vancouver

Vilar-Ribó L, Sánchez-Mora C, Rovira P, Richarte V, Corrales M, Fadeuilhe C, et al. Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2021;186(3):140-150. doi:10.1002/ajmg.b.32827

BibTeX
@article{VilarRib2021,
  author = {Vilar-Ribó, Laura and Sánchez-Mora, Cristina and Rovira, Paula and Richarte, Vanesa and Corrales, Montserrat and Fadeuilhe, Christian and Arribas, Lorena and Casas, Miquel and Ramos-Quiroga, Josep Antoni and Ribasés, Marta and Soler Artigas, María},
  title = {Genetic overlap and causality between substance use disorder and attention‐deficit and hyperactivity disorder},
  journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
  year = {2021},
  volume = {186},
  number = {3},
  pages = {140--150},
  doi = {10.1002/ajmg.b.32827}
}
Kostenlos starten →